Evaluation of bleeding events in patients receiving acalabrutinib therapy.
Kumar PS, Wiczer T, Rosen L, Pollauf AJ, Zheng A, Palettas M, Azali L, Bhat SA, Byrd JC, Grever MR, Rogers KA, Woyach JA, Kittai AS.
Kumar PS, et al.
Leukemia. 2023 Jul;37(7):1554-1557. doi: 10.1038/s41375-023-01869-1. Epub 2023 Mar 17.
Leukemia. 2023.
PMID: 36932166
No abstract available.